Does ERTAPENEM Cause Product prescribing issue? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Product prescribing issue have been filed in association with ERTAPENEM (INVANZ). This represents 0.2% of all adverse event reports for ERTAPENEM.
8
Reports of Product prescribing issue with ERTAPENEM
0.2%
of all ERTAPENEM reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product prescribing issue From ERTAPENEM?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERTAPENEM. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ERTAPENEM Cause?
Drug ineffective (1,001)
Macular degeneration (776)
Off label use (372)
Product use in unapproved indication (346)
Pyrexia (279)
Nausea (277)
Confusional state (263)
Pain (255)
Malaise (220)
Weight decreased (220)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which ERTAPENEM Alternatives Have Lower Product prescribing issue Risk?
ERTAPENEM vs ERTUGLIFLOZIN PIDOLATE
ERTAPENEM vs ERYTHROMYCIN
ERTAPENEM vs ERYTHROMYCIN ETHYLSUCCINATE
ERTAPENEM vs ERYTHROMYCIN LACTOBIONATE
ERTAPENEM vs ERYTHROPOIETIN